¡GoConqr estrena diseño! Cuéntanos qué te parece.

Fichas

Pharmacokinetics

Eric Rogers Pharmacology I Masters in Physician Assistant Inglés 53 fichas

Fichas del conjunto (53)

  1. 1What relationship does PK have?Dose-Concentration
  2. 2What relationship does PD have?Concentration-Effect
  3. 3What are the four steps of Pharmacokinetics?1. Absorption
    2. Distribution
    3. Metabolism
    4. Elimination
  4. 4What are the characteristics of drugs that allow them to transfer across the cell membrane?1. Molecular size and structure (small)
    2. Degree of ionization (non-ionized)
    3. Lipid Solubility (HIGH)
    4. Protein binding (unbound)
  5. 5What can change ionization?pH
  6. 6Definition of AbsorptionTransfer of drug from site of admin to Bloodstream
  7. 7What must oral drugs do to be absorbed? Where? Where do most absorb?Dissolve
    Most dissolve in the stomach and absorb in small intestines
  8. 8Why use Enteric-coated (EC) and Delayed-release (DR) drugs*Dissolve in Small Intestine*
    1. Protect the stomach from drug
    2. Vice versa
    3. Release drug after stomach, target
  9. 9What can you not do with EC or DR drugs?Cut, chew, crush, or dissolve
  10. 10How and where are most drugs absorbed?Via passive transport in the small intestine
  11. 11Relating to the body- Rate and Extent of drug absorption are determined by...Gastric mobility
    Intestinal transit time
    pH
    Surface area
    Food
    Blood flow to absoption site
  12. 12Relating to the drug- Rate and Extent of drug absorption are determined by...Molecular weight
    Degree of ionization
    Lipid/water solubility
    Particle size
    Dosage form
    Concentration
  13. 13Why take a drug with food?May be required for absortion (high fat needed)
    Protection
    Efficacy
    Nausea/vomiting
  14. 14Why take a drug without food?Cation binding, may need to avoid dairy and multivitamins
  15. 15Two ways body tries to get rid of a drug during absorptionP-glycoprotein
    CYP3A4
  16. 16P-glycoproteinEfflux pump - pumps drugs back into gastrointestinal lumen
  17. 17CYP3A4An enzyme in enterocytes of small intestine that breaks down drugs
  18. 18First Pass EffectDrug concentration greatly reduced before systemic circulation
    *AKA First Pass Metabolism*
    Greatly REDUCE Bioavailability (F)
  19. 19Bioavailability (F)Fraction of drug absorbed into systemic circulation after admin
  20. 20Route vs First Pass EffectIntravenous (F=100%)
    Oral (FPE significant)
    Sublingual and Transdermal (Bypass FPE)
    Rectal (Less FPE)
  21. 21Area under curve (AUC)Total drug exposure over time
  22. 22CmaxMaximum concentration of drug in blood
  23. 23Brand name vs genericNeed bioequivalence
    *Can have different excipients (inactive ingredients)
  24. 24BioequivalenceSame rate/extent of absorption
    Also need to show same active ingredient, strength, dosage form, route
  25. 25Define DistributionReversible transfer of a drug between compartments
    (ex. plasma, intersitial fluid, intracellular fluid)
  26. 26Volume of distribution (Vd)Total amnt of drug in body
    ___________________________
    [Drug] in plasma
  27. 27Protein binding - which can act?Unbound (free) drug is available for action
    Bound drug is not available
  28. 28Drug-drug interaction with protein bindingDrugs may compete for plasma protein binding, and may displace one another
  29. 29Blood brain barrierPrevents distribution of many drugs to brain
    *VERY lipophilic can enter
  30. 30Drugs can be store in tissue. T/FTrue
  31. 31Metabolism definitionBiotransformation - chemical alteration of drug in the body
    *think liver*
  32. 32What is the goal of metabolism ?Make drugs easier to excrete
  33. 33During metabolism, how does the body change the drugINCREASES hydophilicity
    Hydrophilic compounds are excreted easier by kidneys
  34. 34What are the two phases of metabolism ?Phase 1 - Oxidation, reduction, hydrolysis
    Phase 2 - Conjugation (addition of molecules to drug)
  35. 35Phase 1 metabolism enzymesCytochrome P-450 enzymes
    (CYP)
  36. 36ProdrugsAre inactive and require biotransformation to active metabolite
  37. 37Drugs may be ______ of CYP enzymes.1. Inducers
    2. Inhibitors
  38. 38Inducers of CYPSlow
    Increase activity by increasing enzyme synthesis
  39. 39Inhibitors of CYPQuick
    Block metabolic activity of CYP enzymes
  40. 40OTC and herbal medicationsIMPORTANT - May cause drug-drug interactions
  41. 41Phase 2 MetabolismConjugation with endogenous substance
    *Usually LARGE and/or POLAR
  42. 42Rate and extent of metabolism determined by...D-D interactions, D-food interactions, Diseases, Age, Environment, Genetics
  43. 43Excretion definitionRemoval of the drug and/or metabolites from the body
  44. 44Principal organ responsible for excretionKidney
  45. 45NephronBasic structural and functional unit of the kidney
  46. 46Four main processes of the nephron.1. Glomerular filtration
    2.. Reabsorption
    3. Secretion
    4. Elimination
  47. 47Glomerular filtration depends on...Plasma protein binding and renal blood flow
  48. 48Glomerular capillariesAre porous.
    Both hydrophilic and lipophilic fall through via gravity.
    Protein bound drugs are too large and will remain in circulation.
  49. 49Clearance (Cl)Volume of plasma that is cleared of drug per unit time
  50. 50Glomerular filtration rate (GFR)-Measure of clearance through kidney, used to make clinical decesions
    -Estimated by calculating Creatinine clearance
    -Normal rate = ~ 120 mL/min
  51. 51Tubular reabsorptionDepends on urine pH and lipid solubility
    *more lipophilic are reabsorbed
  52. 52Half-life (t1/2)Time required for for plasma concentration of drug to decrease by 50%
    *If decrease clearance, INCREASE t1/2*
  53. 53Steady state plasma concentration (Css)Attained after 4-5 half lives

Información

Descripción
Masters in Physician Assistant Pharmacology I Fichas sobre Pharmacokinetics , creado por Eric Rogers el 29/09/2018.
Creado por
Eric Rogers
Visitas
1
Valoración

Escríbenos

¿Sobre qué es tu mensaje?

¿Qué te parece el nuevo diseño?

¿Te gusta?